Bai, Helen Sheeba Devadhasan Aspathi and Rethnaswamy, Gandhimathi (2025) Investigation of Cytotoxicity and Lipid-lowering Effects of Rivea hypocrateriformis Desr. Leaf Extracts on HepG2 Cells: An in vitro Study. Pharmacognosy Magazine, 21 (1). pp. 229-242. ISSN 0973-1296
![[thumbnail of bai-rethnaswamy-2024-investigation-of-cytotoxicity-and-lipid-lowering-effects-of-rivea-hypocrateriformis-desr-leaf.pdf]](https://ir.vistas.ac.in/style/images/fileicons/text.png) Text
            
              
Text
bai-rethnaswamy-2024-investigation-of-cytotoxicity-and-lipid-lowering-effects-of-rivea-hypocrateriformis-desr-leaf.pdf
Download (5MB)
Abstract
Investigation of Cytotoxicity and Lipid-lowering Effects of Rivea hypocrateriformis Desr. Leaf Extracts on HepG2 Cells: An in vitro Study Helen Sheeba Devadhasan Aspathi Bai School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India https://orcid.org/0009-0009-7835-0477 Gandhimathi Rethnaswamy Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, India Background and Purpose
Chronic diseases, such as cardiovascular disease as well as type 2 diabetes, are associated with hyperlipidemia, characterized by high blood lipid levels. HepG2 cells, a human liver cancer cell line, have become a popular model for evaluating the effectiveness of drugs in treating hyperlipidemia. These cells are preferred due to their ability to mimic liver cell physiology and easy maintenance in culture.
   Materials and Methods
In this study, HEP, HEC, HEA, and HEE extracts of Rivea hypocrateriformis were tested on HepG2 cells for cytotoxicity using the MTT assay. The IC 50 values of the extracts were determined and compared to analyze their toxicity. Microscopic images of the cell lines were also examined to observe any structural changes induced by the extracts. 
   Results and Conclusion
The results showed that both HEC and HEE extracts exhibited significant toxicity on HepG2 cells at the highest concentration of 500 µg/ml. Gradual decreases in concentration led to a gradual rise in % cell viability. The IC 50 values of HEC and HEE were calculated to be 61.49 µg/ml and 87.08 µg/ml, respectively, indicating that HEC was slightly more toxic than HEE. According to the results obtained using the vanilla method, HEC and HEE extracts markedly reduced lipid content compared to the oleic acid-induced group. The gene expression regulation of AMPK, FAS, LDL receptor, and HMG-CoA was investigated using the RT-PCR method. The results showed that the extract-treated groups exhibited higher AMPK and LDL receptor gene expression. In contrast, the HEE extract showed higher activity than HEC in suppressing the FAS gene. Overall, the findings suggest that HEC and HEE extracts have potential as anticancer and lipid-lowering agents. Detailed research is needed to understand how the active constituents work. 
    08 26 2024   03 2025   229 242   10.1177/09731296241263660   https://creativecommons.org/licenses/by-nc/4.0/   10.1177/09731296241263660 https://journals.sagepub.com/doi/10.1177/09731296241263660   http://sage.cnpereading.com/paragraph/article/?doi=10.1177/09731296241263660     https://journals.sagepub.com/doi/pdf/10.1177/09731296241263660     https://journals.sagepub.com/doi/pdf/10.1177/09731296241263660   https://journals.sagepub.com/doi/full-xml/10.1177/09731296241263660      10.1016/j.jksus.2022.102256   10.1155/2012/970635   10.4103/0974-8520.182755   10.3389/fnut.2021.775382   10.1007/s10600-018-2277-3   10.1038/s41598-018-27420-2   10.1182/blood.V52.6.1099.1099   Médecine Therapeutique Khan A. A. 1 19 1 2019   10.1038/emm.2016.16 Kim J., Yang G., Kim Y., Kim J. & Ha J. (2016). AMPK activators: Mechanisms of action and physiological activities.   10.2337/db06-0006   10.3389/fphar.2022.857956   10.1007/s10068-010-0179-7   10.3390/foods8060185   10.1186/s12906-020-03162-5   10.1177/2053951716666102   Plant Growth Regulation Marshall N. J. 69 5 2 1995   10.1016/0022-1759(83)90303-4   10.1155/2022/9099672   Pharmaceutical Sciences and Research Patel V. B. 85 1 12 2010   10.1007/s10482-015-0524-1   Current Bioactive Compounds Rotimi D. 21 18 5 2022   10.3748/wjg.v20.i9.2279   10.1016/S2213-8587(19)30388-2   10.1021/jf900730e   10.1074/jbc.M408149200
| Item Type: | Article | 
|---|---|
| Subjects: | Pharmacology > Drug Relations | 
| Domains: | Pharmacology | 
| Depositing User: | Mr IR Admin | 
| Date Deposited: | 28 Aug 2025 07:29 | 
| Last Modified: | 28 Aug 2025 07:29 | 
| URI: | https://ir.vistas.ac.in/id/eprint/10660 | 



 Dimensions
 Dimensions Dimensions
 Dimensions